Incidence of Post-operative Delirium with Use of Benzodiazepines in Adult Cardiac Surgery: A Comparative Study of On-Pump and Off-Pump Procedures
Journal of Cardiac Critical Care TSS · 19.01.2026 · 10 · 59-62
DOI: 10.25259/jccc_52_2025 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Cardiac Critical Care TSS, online erschienen am 19.01.2026. Verfasst von Bhakti Ravindra Patil. Die Arbeit nennt 41 Literaturangaben.
Themen: Delir
Abstract (Originalsprache)
Objectives
To compare the incidence of postoperative delirium between on-pump and off-pump adult cardiac surgery patients receiving standardized midazolam induction. Material and Methods: Prospective observational study including 100 adults (50 on-pump, 50 off-pump). All patients received midazolam 0.05 mg/kg IV during induction. Post-operative delirium (POD) was assessed using CAM-ICU at 6, 12, 24, and 48 hours postoperatively.
Results
POD incidence was 16% in on-pump and 12% in off-pump patients (P = 0.57), showing no statistically significant difference.
Conclusion
Short-term peri-induction midazolam use did not significantly influence POD incidence, supporting its safety when used briefly in adult cardiac surgery.
Zitieren
APA
Patil, B. R. (2026). Incidence of Post-operative Delirium with Use of Benzodiazepines in Adult Cardiac Surgery: A Comparative Study of On-Pump and Off-Pump Procedures. Journal of Cardiac Critical Care TSS, 10, 59-62. https://doi.org/10.25259/jccc_52_2025
Vancouver
Patil BR. Incidence of Post-operative Delirium with Use of Benzodiazepines in Adult Cardiac Surgery: A Comparative Study of On-Pump and Off-Pump Procedures. Journal of Cardiac Critical Care TSS. 2026;10:59-62. doi:10.25259/jccc_52_2025
BibTeX
@article{Patil2026,
author = {Patil, Bhakti Ravindra},
title = {Incidence of Post-operative Delirium with Use of Benzodiazepines in Adult Cardiac Surgery: A Comparative Study of On-Pump and Off-Pump Procedures},
journal = {Journal of Cardiac Critical Care TSS},
year = {2026},
volume = {10},
pages = {59--62},
doi = {10.25259/jccc_52_2025}
}
EUVIMED